<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Arvelle Therapeutics &#8211; Retail Institute Italy</title>
	<atom:link href="https://retailinstitute.it/tag/arvelle-therapeutics/feed/" rel="self" type="application/rss+xml" />
	<link>https://retailinstitute.it</link>
	<description>Retail Institute Italy</description>
	<lastBuildDate>Fri, 08 Jan 2021 15:26:52 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=5.5.18</generator>

<image>
	<url>https://retailinstitute.it/wp-content/uploads/2019/01/cropped-Favicon_retail-32x32.jpg</url>
	<title>Arvelle Therapeutics &#8211; Retail Institute Italy</title>
	<link>https://retailinstitute.it</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Farmaceutica, Angelini acquista la svizzera Arvelle per 960 milioni di dollari</title>
		<link>https://retailinstitute.it/farmaceutica-angelini-acquista-la-svizzera-arvelle-per-960-milioni-di-dollari/</link>
		
		<dc:creator><![CDATA[vmuti]]></dc:creator>
		<pubDate>Mon, 04 Jan 2021 15:23:40 +0000</pubDate>
				<category><![CDATA[Dal Mondo]]></category>
		<category><![CDATA[News dei Soci]]></category>
		<category><![CDATA[acquisizione]]></category>
		<category><![CDATA[Angelini]]></category>
		<category><![CDATA[Arvelle Therapeutics]]></category>
		<category><![CDATA[Farmaceutica]]></category>
		<category><![CDATA[Svizzera]]></category>
		<guid isPermaLink="false">https://retailinstitute.it/?p=555484</guid>

					<description><![CDATA[<p>Maxi acquisizione in svizzera per Angelini Pharma. L&#8217;azienda farmaceutica italiana ha acquistato la svizzera Arvelle Therapeutics, attiva nei trattamenti per pazienti affetti da disturbi del sistema nervoso centrale. La valutazione &#8230; </p>
<p>L'articolo <a rel="nofollow" href="https://retailinstitute.it/farmaceutica-angelini-acquista-la-svizzera-arvelle-per-960-milioni-di-dollari/">Farmaceutica, Angelini acquista la svizzera Arvelle per 960 milioni di dollari</a> proviene da <a rel="nofollow" href="https://retailinstitute.it">Retail Institute Italy</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
